Propanc Biopharma has filed documents with the U.S. Securities and Exchange Commission regarding a reselling plan of common shares initiated by selling shareholders.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to the filing information, the maximum number of common shares proposed for resale under this plan is up to 15 million shares. This submission signals that the selling shareholders may conduct large-scale share sales in the public market. Relevant details have been specified in the SEC filing, and the market will closely monitor the potential impact of this move on the company’s equity structure and the secondary market share price.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Research shows that Polymarket's accuracy mainly comes from 3% of traders
AIcoin•2026/04/26 13:52
Iranian Official: Vessels Passing Through the Strait of Hormuz Must Pay Fee
BlockBeats•2026/04/26 13:23
Michael Saylor shares another bitcoin Tracker update, may disclose additional holdings data next week
Chaincatcher•2026/04/26 13:13
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$78,039.95
+0.46%
Ethereum
ETH
$2,347.45
+1.34%
Tether USDt
USDT
$1
+0.01%
XRP
XRP
$1.43
-0.12%
BNB
BNB
$632.01
+0.29%
USDC
USDC
$0.9998
+0.01%
Solana
SOL
$86.44
-0.10%
TRON
TRX
$0.3238
+0.14%
Dogecoin
DOGE
$0.09884
+0.44%
Hyperliquid
HYPE
$41.3
-0.55%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now